{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:56:55Z","timestamp":1790582215554,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007613","name":"Ankara University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.abd.2026.501457","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:05:47Z","timestamp":1787922347000},"page":"501457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful treatment of rituximab-refractory pemphigus vulgaris with Obinutuzumab"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7459-2729","authenticated-orcid":false,"given":"Muhammet Talha","family":"Sara\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Ayg\u00fcn Alizada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan Merve","family":"Erol Mart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Boyvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"\u015eanl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"\u00d6ktem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501457_bib0005","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2026.501457_bib0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.12649","article-title":"Grading criteria for disease severity by pemphigus disease area index","volume":"41","author":"Shimizu","year":"2014","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2026.501457_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.14405","article-title":"Calculation of cut-off values based on the autoimmune bullous skin disorder \u0131ntensity score and pemphigus disease area \u0131ndex pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus","volume":"175","author":"Boulard","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2026.501457_bib0020","series-title":"GAZYVA, obinutuzumab injection, for intravenous use: prescribing information [Internet]","year":"2025"},{"key":"10.1016\/j.abd.2026.501457_bib0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/bjd\/ljaf201","article-title":"Successful treatment of pemphigus vulgaris with obinutuzumab","volume":"193","author":"Tang-Whitmore","year":"2025","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2026.501457_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100813","article-title":"Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine","volume":"46","author":"Kuriyama","year":"2022","journal-title":"Curr Probl Cancer."},{"key":"10.1016\/j.abd.2026.501457_bib0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jdcr.2022.07.011","article-title":"Obinutuzumab in a patient with chronic lymphocytic leukemia-associated paraneoplastic pemphigus","volume":"27","author":"Freund","year":"2022","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.abd.2026.501457_bib0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jdcr.2025.10.065","article-title":"Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab","volume":"67","author":"Hiel","year":"2025","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.abd.2026.501457_bib0045","article-title":"The effectiveness and safety of ofatumumab for the treatment of pemphigus vulgaris: a cohort study based on a registry database","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:25:43Z","timestamp":1790580343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059626001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0365059626001704"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501457","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of rituximab-refractory pemphigus vulgaris with Obinutuzumab","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501457"}}